Test Bank for Advanced Pharmacology for
Prescribers 1st Edition Luu Kayingo
complete guide with rationale
, Table of Contents
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ............................................. 3
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................... 13
Chapter4: Pharmacogenetics and Pharmacogenomics ................................................................................ 25
Chapter 5: Pharmacology Across the Life Span ........................................................................................ 30
Chapter 6: Drug-Therapy Prescribing in Special Populations.................................................................... 36
Chapter 7: Drug Development and Approval............................................................................................. 45
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
Substance Prescribing Chapter 10: Antibiotic Stewardship ........................................................................ 51
Chapter 11: Applied Calculations for Prescribing...................................................................................... 58
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapte
r 14: Pharmacotherapy for Eye Conditions ................................................................................................. 67
Chapter 15: Pharmacotherapy for Skin Conditions .................................................................................... 74
Chapter 16: Pharmacotherapy for Neurologic Conditions ......................................................................... 81
Chapter 17: Pharmacotherapy for Cardiovascular Conditions ................................................................... 94
Chapter 18: Pharmacotherapy for Respiratory Conditions....................................................................... 106
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Supp
ort............................................................................................................................................................... 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................... 128
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ......................... 133
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions............................... 146
Chapter 23: Therapeutic Applications of Immunology and Vaccines..................................................... 158
Chapter 24: Pharmacotherapy for Endocrine Disorders........................................................................... 163
Chapter 25: Pharmacotherapy for Hematologic Disorders ....................................................................... 174
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist.................................... 190
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions .................................................. 196
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ....................................................... 211
Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................... 217
Chapter 30: Antimicrobial Pharmacotherapy ............................................................................................ 224
Chapter 31: Antiretroviral Pharmacotherapy ............................................................................................ 235
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neuro
cognitive Conditions .................................................................................................................................. 247
Chapter 33: Pharmacotherapy for Pain Management ............................................................................... 257
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ....................................... 267
Chapter 35: Over-the-Counter Medications.............................................................................................. 283
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
MULTIPLE CHOICE
• What is the primary purpose of the nursing assessment?
A. Identifying underlying pathologic conditions
B. Assisting the physician in identifying medical conditions
C. Determining the patients mental status
D. Exploring patient responses to health problems
ANS: D
A nursing assessment is done to identify the patients response to health pr
oblems. During the nursing assessment phase, a comprehensive informati
on base is developed through a physical examination, nursing history, me
dication history, and professional observation. Identifying underlying path
ologic conditions and assisting the physician in identifying medical condit
ions is not part of the nursing process. Determining the patients mental st
atus is one part of the nursing assessment, but it is not the primary purp
ose.
DIF: Cognitive Level: Comprehension
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
Process Step: Assessment
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
• What is the basis of the NANDA I taxonomy?
A. Functional health patterns
B. Human response patterns
C. Basic human needs
D. Pathophysiologic needs
ANS: B
The NANDA I taxonomy identifies human response patterns. Functio
nal components of health patterns are limited to activity, fluid volume, n
utrition, self care, and sensory perception. Basic human needs comprise l
ess than merely health patterns. Pathophysiologic needs are not part of t
he scope of NANDA I.
, DIF: LCognitive LLevel: LKnowledge
LRE LF: Lpp. L37-38 LOBJ: L5 LTOP:
Nursing L Process L Step: LDiagnosis
MSC: LNCLEX L Client L Needs L Category: L Physiological L Integrity
• Which Ltask L is Lincluded L in Lthe L assessment L step L of Lthe L nursing L process?
A. Establishing L patient L goals/outcomes
B. Implementing L the L nursing L care L plan L (NCP)
C. Measuring L goal/outcome L achievement
D. Collecting L and L communicating L data
ANS:RD
Data Lare Lcollected Land Lcommunicated Lin Lthe Lassessment Lphase Lof
Lthe Lnursi Lng Lprocess. LEstablishing Lgoals Lis Lthe Lfunction Lof
Lplanning.
Implementing Lthe LNCP Lis Lthe Lfunction Lof Limplementation.
LMeasuring Loutc Lome Lachievement Lis Lthe Lfunction Lof Levaluation.
DIF: LCognitive LLevel:
LComprehension LREF: Ldm L36
LOBJ: L2 L| L3 LTOP: LNursing
LProcess LStep: LAssessment
MSC: LNCLEX L Client L Needs L Category: L Health L Promotion Land L Maintenance
• Which Lstatement L regarding L nursing L diagnoses L is L accurate?
a. Nursing L diagnoses Lremain Lthe L same L for Las L long Las L the L disease L is
L present.
b. Nursing L diagnoses L are L written L to L identify Ldisease Lstates.
c. Nursing L diagnoses L describe L patient L problems L that L nurses L treat.
d. Nursing L diagnoses L identify L causes L related L to L illness.
ANS: LC
Diagnostic Lstatements Lidentify Lproblems La Lnurse Lis Lindependently
Lable Lto Ltreat Lwithin Lthe Lscope Lof Lprofessional Lpractice. LNursing
Ldiagnoses Lvary Lwi Lth Lthe Lchanging Lcondition Lof Lthe Lpatient. LThe
Lresponse Lpatterns Lare Lunique Lto Lthe L patient Land Lare Lnot Ldisease
Lspecific. L Nursing Ldiagnoses L describe Lth L e Lpatients Lhuman
Lresponse Lpattern.
DIF: L Cognitive L Level: L Comprehension
Prescribers 1st Edition Luu Kayingo
complete guide with rationale
, Table of Contents
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ............................................. 3
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................... 13
Chapter4: Pharmacogenetics and Pharmacogenomics ................................................................................ 25
Chapter 5: Pharmacology Across the Life Span ........................................................................................ 30
Chapter 6: Drug-Therapy Prescribing in Special Populations.................................................................... 36
Chapter 7: Drug Development and Approval............................................................................................. 45
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
Substance Prescribing Chapter 10: Antibiotic Stewardship ........................................................................ 51
Chapter 11: Applied Calculations for Prescribing...................................................................................... 58
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapte
r 14: Pharmacotherapy for Eye Conditions ................................................................................................. 67
Chapter 15: Pharmacotherapy for Skin Conditions .................................................................................... 74
Chapter 16: Pharmacotherapy for Neurologic Conditions ......................................................................... 81
Chapter 17: Pharmacotherapy for Cardiovascular Conditions ................................................................... 94
Chapter 18: Pharmacotherapy for Respiratory Conditions....................................................................... 106
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Supp
ort............................................................................................................................................................... 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................... 128
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ......................... 133
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions............................... 146
Chapter 23: Therapeutic Applications of Immunology and Vaccines..................................................... 158
Chapter 24: Pharmacotherapy for Endocrine Disorders........................................................................... 163
Chapter 25: Pharmacotherapy for Hematologic Disorders ....................................................................... 174
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist.................................... 190
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions .................................................. 196
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ....................................................... 211
Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................... 217
Chapter 30: Antimicrobial Pharmacotherapy ............................................................................................ 224
Chapter 31: Antiretroviral Pharmacotherapy ............................................................................................ 235
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neuro
cognitive Conditions .................................................................................................................................. 247
Chapter 33: Pharmacotherapy for Pain Management ............................................................................... 257
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ....................................... 267
Chapter 35: Over-the-Counter Medications.............................................................................................. 283
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
MULTIPLE CHOICE
• What is the primary purpose of the nursing assessment?
A. Identifying underlying pathologic conditions
B. Assisting the physician in identifying medical conditions
C. Determining the patients mental status
D. Exploring patient responses to health problems
ANS: D
A nursing assessment is done to identify the patients response to health pr
oblems. During the nursing assessment phase, a comprehensive informati
on base is developed through a physical examination, nursing history, me
dication history, and professional observation. Identifying underlying path
ologic conditions and assisting the physician in identifying medical condit
ions is not part of the nursing process. Determining the patients mental st
atus is one part of the nursing assessment, but it is not the primary purp
ose.
DIF: Cognitive Level: Comprehension
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
Process Step: Assessment
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
• What is the basis of the NANDA I taxonomy?
A. Functional health patterns
B. Human response patterns
C. Basic human needs
D. Pathophysiologic needs
ANS: B
The NANDA I taxonomy identifies human response patterns. Functio
nal components of health patterns are limited to activity, fluid volume, n
utrition, self care, and sensory perception. Basic human needs comprise l
ess than merely health patterns. Pathophysiologic needs are not part of t
he scope of NANDA I.
, DIF: LCognitive LLevel: LKnowledge
LRE LF: Lpp. L37-38 LOBJ: L5 LTOP:
Nursing L Process L Step: LDiagnosis
MSC: LNCLEX L Client L Needs L Category: L Physiological L Integrity
• Which Ltask L is Lincluded L in Lthe L assessment L step L of Lthe L nursing L process?
A. Establishing L patient L goals/outcomes
B. Implementing L the L nursing L care L plan L (NCP)
C. Measuring L goal/outcome L achievement
D. Collecting L and L communicating L data
ANS:RD
Data Lare Lcollected Land Lcommunicated Lin Lthe Lassessment Lphase Lof
Lthe Lnursi Lng Lprocess. LEstablishing Lgoals Lis Lthe Lfunction Lof
Lplanning.
Implementing Lthe LNCP Lis Lthe Lfunction Lof Limplementation.
LMeasuring Loutc Lome Lachievement Lis Lthe Lfunction Lof Levaluation.
DIF: LCognitive LLevel:
LComprehension LREF: Ldm L36
LOBJ: L2 L| L3 LTOP: LNursing
LProcess LStep: LAssessment
MSC: LNCLEX L Client L Needs L Category: L Health L Promotion Land L Maintenance
• Which Lstatement L regarding L nursing L diagnoses L is L accurate?
a. Nursing L diagnoses Lremain Lthe L same L for Las L long Las L the L disease L is
L present.
b. Nursing L diagnoses L are L written L to L identify Ldisease Lstates.
c. Nursing L diagnoses L describe L patient L problems L that L nurses L treat.
d. Nursing L diagnoses L identify L causes L related L to L illness.
ANS: LC
Diagnostic Lstatements Lidentify Lproblems La Lnurse Lis Lindependently
Lable Lto Ltreat Lwithin Lthe Lscope Lof Lprofessional Lpractice. LNursing
Ldiagnoses Lvary Lwi Lth Lthe Lchanging Lcondition Lof Lthe Lpatient. LThe
Lresponse Lpatterns Lare Lunique Lto Lthe L patient Land Lare Lnot Ldisease
Lspecific. L Nursing Ldiagnoses L describe Lth L e Lpatients Lhuman
Lresponse Lpattern.
DIF: L Cognitive L Level: L Comprehension
